Leonard Schleifer
Chief Executive Officer en REGENERON PHARMACEUTICALS, INC. .
Fortuna: 2 331 M $ al 31/03/2024
Perfil
Fundador de Regeneron Pharmaceuticals, Inc., Leonard S. Schleifer es copresidente, consejero delegado y director de esta empresa. Anteriormente fue profesor adjunto en el Weill Cornell Medical College. El Dr. Schleifer se doctoró en la Universidad de Virginia.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
11/04/2023 | 1 726 565 ( 82.61% ) | 1 662 M $ | 31/03/2024 | |
11/12/2023 | 695 330 ( 0.64% ) | 669 M $ | 31/03/2024 |
Cargos activos de Leonard Schleifer
Empresas | Cargo | Inicio |
---|---|---|
REGENERON PHARMACEUTICALS, INC. | Chief Executive Officer | 08/01/1988 |
Regeneron Ireland DAC
Regeneron Ireland DAC BiotechnologyHealth Technology Part of Regeneron Pharmaceuticals, Inc., Regeneron Ireland DAC is a leading Irish biotechnology company that uses science to develop new medicines for patients. The private company is located in Ireland. The company successfully manufactures a range of biopharmaceuticals for patients worldwide, including approved therapeutic proteins and those involved in clinical studies. | Chief Executive Officer | 01/01/2013 |
Antiguos cargos conocidos de Leonard Schleifer.
Empresas | Cargo | Fin |
---|---|---|
Weill Cornell Medical College | Corporate Officer/Principal | - |
Formación de Leonard Schleifer.
University of Virginia | Doctorate Degree |
Cornell University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
REGENERON PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Regeneron Ireland DAC
Regeneron Ireland DAC BiotechnologyHealth Technology Part of Regeneron Pharmaceuticals, Inc., Regeneron Ireland DAC is a leading Irish biotechnology company that uses science to develop new medicines for patients. The private company is located in Ireland. The company successfully manufactures a range of biopharmaceuticals for patients worldwide, including approved therapeutic proteins and those involved in clinical studies. | Health Technology |
- Bolsa de valores
- Insiders
- Leonard Schleifer